Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07229820

Efficacy and Safety of ZSP1273 in Adolecent 12-17 Years Old With Influenza A

Conditions: Influenza A

Sex: All
Ages: 12 Years – 17 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 157
Sponsor: Guangdong Raynovent Biotech Co., Ltd

Location: Ruijin Hospital Shanghai

Summary

This trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.

Eligibility Criteria

Inclusion Criteria: 1. Participants and their guardians who are able to understand the study and comply with all study procedures, and willing to provide written informed consent/assent prior to the predose examinations appropriately. 2. Male or female participants aged ≥ 2 to ≤11 years at the time of signing the informed consent form. 3. Participants with a diagnosis of influenza virus infection confirmed by all of the following: 1. Positive rapid antigen test (RAT) for influenza with nasal or throat swabs; 2. The time interval between the onset of symptoms and enrollment is 48 hours or less; 3. Fever ≥ 38ºC (axillary temperature); and at least one following respiratory symptoms associated with influenza virus infection is present Exclusion Criteria: 1. Participants with severe influenza virus infection; 2. Participants with any medical history in gastrointestinal that interferes with the absorption of drugs; 3. Immunodeficiency,including malignant tumor,organ or marrow transplant,human immunodeficiency virus \[HIV\] infection,or patients receiving immunosuppressant therapy 3 months prior to enrollment; 4. Have received any other investigational products within 3 months prior to dosing; 5. Positive urine pregnancy test; 6. Participants with concurrent infections requiring antimicrobial therapy; 7. Participants who are considered inappropriate for the study by the investigator.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07229820). StuddyBuddy aggregates publicly available trial information.